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Abstract
Epidemiological data regarding tetanus and diphtheria immunity in
elderly people in Brazil are scarce. During the First National Immuni-
zation Campaign for the Elderly in Brazil in April 1999, 98 individu-
als (median age: 84 years) received one tetanus-dyphtheria (Td)
vaccine dose (Butantan Institute, lot number 9808079/G). Inclusion
criteria were elderly individuals without a history of severe immuno-
suppressive disease, acute infectious disease or use of immunomodu-
lators. Blood samples were collected immediately before the vaccine
and 30 days later. Serum was separated and stored at -20oC until
analysis. Tetanus and diphtheria antibodies were measured by the
double-antigen ELISA test. Tetanus and diphtheria antibody concen-
trations lower than 0.01 IU/mL were considered to indicate the
absence of protection, between 0.01 and 0.09 IU/mL were considered
to indicate basic immunity, and values of 0.1 IU/mL or higher were
considered to indicate full protection. Before vaccination, 18% of the
individuals were susceptible to diphtheria and 94% were susceptible
to tetanus. After one Td dose, 78% became fully immune to diphthe-
ria, 13% attained basic immunity, and 9% were still susceptible to the
disease. In contrast, 79% remained susceptible to tetanus, 4% had
basic immunity and 17% were fully immune. Although one Td dose
increases immunity to diphtheria in many elderly people who live in
Brazil, a complete vaccination series appears to be necessary for the
prevention of tetanus.
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Introduction
The impact of routine childhood immu-
nization on the epidemiology of many dis-
eases is well known. A clear example is the
dramatic decline in the incidence of diphthe-
ria in industrialized countries (1). In parallel,
many of these countries have realized that
large segments of their adult populations are
susceptible to diphtheria (2) as a consequence
of the decrease in the asymptomatic carrier
status of toxigenic Corynebacterium diph-
theriae and of the natural boosters that used
to occur in the pre-vaccination era. When the
circulation of toxigenic strains of C. diphthe-
riae is reduced, repeated doses of diphtheria
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toxoid are needed to maintain immunity in
the adult population (3).
However, acquisition of immunity against
other diseases has not changed with time:
protection against tetanus, for instance, can
only be achieved through vaccination of
each individual and subsequent boosters are
needed in order to maintain protective anti-
body levels (4).
Vaccination of the elderly population has
now been recommended as a routine in some
countries (5). Assessing immunity to vac-
cine-preventable diseases in the elderly is
necessary in order to provide a correct im-
munization scheme.
In Brazil, the First National Influenza,
Pneumococcus, Tetanus and Diphtheria Vac-
cination Campaign for the Elderly took place
in 1999 (6). In order to identify immunity
before the introduction of that program and
the effect of the administration of one dose
of tetanus and diphtheria vaccine (Td) on
that population, we tested tetanus and diph-
theria antibodies in 98 individuals pre- and
post-vaccination.
Material and Methods
The study was conducted at a Nursing
Home in São Paulo, SP, Brazil, during the
First National Immunization Campaign for
the Elderly in April 1999. Written informed
consent was obtained from participants and/
or their legal guardians before enrollment in
the study.
Inclusion criteria were elderly individu-
als without a history of severe immunosup-
pressive disease, acute infectious disease or
use of immunomodulators. Ninety-eight of
the 120 patients who participated in the ma-
jor study were selected because serum
samples were available before and after the
administration of a Td dose. The median age
of the 98 participants was 84 years (range:
68 to 99); 23.5% were men and 76.5%
women. Most were individuals originally
from Eastern Europe who had immigrated to
Brazil in the last 60 years and had been
living in a nursing home for more than 8
years. Only 12.3% of them reported previ-
ous tetanus vaccination and no data were
available for diphtheria vaccination.
All individuals received one dose (0.5
mL) of Td vaccine (Butantan Institute, São
Paulo, SP, Brazil) containing 10 Lf (Limes
flocculation unit) per dose of tetanus toxoid
and 2 Lf per dose of diphtheria toxoid
adsorbed onto aluminum toxoid and with
thimerosal as a preservative. Blood samples
were collected from all participants immedi-
ately before vaccination and 30 days after
the procedure. Serum was separated and
stored at -20ºC until analysis. Antibodies
against tetanus and diphtheria were meas-
ured by the double-antigen ELISA test, as
previously described (7).
Tetanus toxoid (Butantan Institute) di-
luted in 0.1 M carbonate-bicarbonate buffer,
pH 9.6, was used to coat 96-well microtiter
plates (Thermolab System, Chantilly, VA,
USA) overnight at 4ºC. Two-fold serial dilu-
tions of serum samples and of tetanus refer-
ence serum (in-house standard calibrated
against “Tetanus antitoxin human immuno-
globulin NIBSC reagent 1976 (76/589)”) in
dilution buffer (10 mM PBS, pH 7.2, 1%
Triton X-100) with 1% bovine serum albu-
min were added to the plate and incubated
for 1 h at 37ºC. Biotin-labeled tetanus toxoid
in dilution buffer was then added to the plate
and incubated for 1 h at 37ºC. Streptavidin-
alkaline phosphatase conjugate (Zymed, San
Francisco, CA, USA) in dilution buffer was
incubated for 1 h at 37ºC. p-Nitrophenyl-
phosphate (Sigma, St. Louis, MO, USA) in 1
M diethanolamine, 5 mM magnesium chlo-
ride buffer, pH 9.8, was used as substrate
and absorbance at 450 nm was read with an
immunoreader ELX-800 (Bio-Tek Instru-
ments, Winooski, VT, USA). Between steps,
the plate was washed five times in dilution
buffer.
 The same method was used for diphthe-
ria antibodies, with some modifications: diph-
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theria toxoid (Butantan Institute), diphtheria
reference serum (in-house standard calibrated
against “Diphtheria antitoxin human serum
91/534” - NIBSC reagent) and biotin-la-
beled diphtheria toxoid were used.
Tetanus and diphtheria antibodies are
reported as IU/mL using the curve compari-
son method to transform optical density to
concentration units.
Patients were classified according to in-
ternationally accepted criteria of protective
antibody levels (8-12). Tetanus and diphthe-
ria antibody concentrations lower than 0.01
IU/mL were considered to indicate the ab-
sence of protection, between 0.01 and 0.09
IU/mL were considered to indicate basic
immunity, and values of 0.1 IU/mL or higher
were considered to indicate full protection.
Due to the non-normal distribution of the
data, values were log-transformed before
comparison between pre- and post-booster
mean antibody concentrations by the paired
t-test. The chi-square test was used to evalu-
ate a possible association between booster
and categories of immunity to tetanus and
diphtheria.
Results
Categories of immunity to tetanus and
diphtheria based on pre- and
post-vaccination antibodies
Before one Td vaccine dose, the majority
of the individuals analyzed had some degree
of immunity against diphtheria (absence of
immunity: 18%; basic immunity: 37%; full
immunity: 45%). By contrast, 94% of them
were susceptible to tetanus and the remain-
ing 6% had only basic immunity.
After vaccination, 78% of the subjects
were fully immune to diphtheria, 13% had
basic immunity and 9% remained suscep-
tible. For tetanus, the post-vaccination pro-
portions were: 17% fully immune, 4% with
basic immunity and 79% still without pro-
tection. For both diseases, the proportions of
individuals in each category of immunity
were significantly different pre- and post-
vaccination, with an increase in the percent-
age of immune subjects (P < 0.001 for diph-
theria and tetanus, chi-square test; Table 1).
Diphtheria antibodies pre- and
post-vaccination
As observed when categories of immuni-
ty were analyzed, geometric mean antibody
values increased with one Td dose (diphthe-
ria: pre-Td, 0.072 and post-Td, 1.456 IU/
mL, t-test, P < 0.001; tetanus: pre-Td, 0.005
and post-Td, 0.014 IU/mL, t-test, P < 0.001).
Of note, diphtheria geometric mean anti-
body concentrations were statistically higher
than tetanus values before and after vaccina-
tion (P < 0.001 for both comparisons, t-test;
Figure 1).
Interestingly, women responded better
than men to the booster dose: while diphthe-
ria geometric mean antibodies increased sig-
nificantly for men (pre-Td, 0.060 and post-
Td, 0.897 IU/mL, P < 0.001, t-test) and
women (pre-Td, 0.077 and post-Td, 1.689
IU/mL, P < 0.001, t-test), only women had
an increase in tetanus geometric mean anti-
bodies (women: pre-Td, 0.005 and post-Td,
0.017 IU/mL, P < 0.001, t-test; men: pre-Td,
0.005 and post-Td, 0.007 IU/mL, P = 0.187,
t-test).
Table 1. Effect of a single tetanus-diphtheria vaccination on the categories of immunity
to both diseases in elderly subjects at the time of vaccination and 30 days later.
Pre-vaccination Post-vaccination
Diphtheria*
Absence of immunity (<0.01 IU/mL) 18 (18%) 9 (9%)
Basic immunity (≥0.01 and <0.1 IU/mL) 36 (37%) 13 (13%)
Full immunity (≥0.1 IU/mL) 44 (45%) 76 (78%)
Tetanus*
Absence of immunity (<0.01 IU/mL) 92 (94%) 77 (79%)
Basic immunity (≥0.01 and <0.1 IU/mL) 6 (6%) 4 (4%)
Full immunity (≥0.1 IU/mL) 0 (0%) 17 (17%)
Data are reported as number and percent. *P < 0.001, categories of pre-vaccination
compared to post-vaccination for both diphtheria and tetanus (chi-square test).
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Discussion
We observed that, although the majority
of individuals in our study group were fully
protected against diphtheria, only 6% of them
had basic immunity to tetanus and none had
tetanus antibodies that would confer full
protection. After one Td dose, a shift to
higher categories of immunity was observed
for both tetanus and diphtheria. However,
the contrast between protection against the
two diseases was maintained, with the vast
majority of the individuals still being sus-
ceptible to tetanus and now fully immune to
diphtheria.
Our tetanus results agree with data re-
ported by other groups in different countries
(4). Our epidemiologic situation regarding
diphtheria is probably situated between that
of industrialized and non-industrialized coun-
tries (8,9). There was a high percentage of
individuals with pre-vaccination immunity
to diphtheria who, analyzed together, dis-
played low geometric mean antibody con-
centrations (0.072 IU/mL). This suggests
previous C. diphtheriae infection with rare
subsequent exposures to the bacillus (2).
Indeed, diphtheria has been decreasing in
Brazil over the last decades, with an inci-
dence of 0.01 to 0.04 cases per 100,000
inhabitants in the State of São Paulo during
the last few years (13).
For this reason, one Td dose had an effect
suggestive of a diphtheria booster on the ma-
jority of the population. On the other hand,
although mean tetanus antibodies increased
after one dose, the persistence of so many still
susceptible individuals indicates that this was
their primary contact with the antigen. Inter-
estingly, when analyzed separately, women
showed a better immune response to tetanus
(but not to diphtheria) than men.
As also reported by others (14,15), we
have shown that elderly individuals can re-
spond to tetanus and diphtheria toxoids.
However, even for diphtheria, a single vac-
cine dose was insufficient to obtain adequate
protection for those who had not been previ-
ously exposed to the antigen (16).
As is the case for other developing coun-
tries, Brazil has a growing elderly population
(17) that is now exposed to a different environ-
ment with less natural booster stimuli when
compared with that of previous decades. This
emphasizes the necessity of a complete vacci-
nation series for elderly people without a record
of immunization. Unfortunately, as already
noticed by others (18), even in developed
countries, recommendations for immuniza-
tion practices as part of health maintenance in
this population may not be adhered to ad-
equately in the primary care setting.
As a “catch up” strategy and in parallel to
routine vaccination, the aged in Brazil are
having their tetanus and diphtheria immuniza-
tion updated during the National Vaccination
Campaign for the Elderly that is held yearly
since 1999 and they are subsequently referred
to routine health care services to complete the
primary series. Studies are underway to assess
immunity against tetanus and diphtheria after
the first years of this strategy.
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Figure 1. Tetanus and diphtheria antibodies pre- and post-one tetanus-diphtheria (Td)
vaccination. Horizontal lines in boxplots indicate the 25th, 50th, and 75th percentiles.
Outlying values (present only for tetanus) are depicted as asterisks. Geometric means (GM)
are shown at the bottom of the figure.
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